Bicara Therapeutics INC
+$392.7M
Net Activity
Institutions Holding
147
Popularity Rank
#3592
Avg Weight
0.97%
Total Value
$1.4B
147 institutions currently hold BCAX, with 81 net buyers and 61 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
61
Net Buying Institutions
81
Top 5 by Value
Across its top 20 institutional holders, BCAX's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 25/100, avg. turnover score 32/100).
+$1.0B
Total Buy Value
$176.9M
Total Sell Value
81
Net Buyers
61
Net Sellers
BCAX does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
6
Filings (90d)
$4.80M
Total Est. Value
168K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Mazumdar Claire | 2026-07-10 | $297K |
| Cohlhepp Ryan | 2026-07-08 | $870K |
| Hyep Ivan | 2026-07-08 | $847K |
| DAVID RABEN | 2026-07-08 | $1.43M |
| Lara Meisner | 2026-07-07 | $30K |
| Raben David | 2026-06-25 | $1.32M |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
055477103
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter